2BB score and signals
Prelude Therapeutics Incorporated’s current 2BB score is 20 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 22 | Low |
| Momentum | 10 | Strongly Weakening |
| Financial strength | 37 | Weak |
| Quality | 70 | Strong |
| Risk | 64 | High |
Company facts
| Headquarters | Wilmington, Delaware, United States |
| Founded | 2016 |
| Employees | 79 |
| 52-week range | $1.16 – $6.83 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2027-03-08 | — | -0.1836 | — | $3.63M |
| 2026-11-10 | — | 0.0952 | — | $37.74M |
| 2026-08-19 | — | -0.2006 | — | $0.00 |
| 2026-05-12 | -0.13 | -0.2533 | $4.58M | $0.00 |
Related companies
2BBBullish & Bearish